Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-02-15 Risser Eric Blasius Chief Operating Officer Grant or award · Employee stock option (right to buy) +200,000 200,000
2023-02-15 Risser Eric Blasius Chief Operating Officer Grant or award · Restricted Stock Unit +50,000 50,000
2023-02-15 Cilinski Lynn VP, Controller and Treasurer Grant or award · Employee stock option (right to buy) +75,000 75,000
2023-02-15 Cilinski Lynn VP, Controller and Treasurer Grant or award · Restricted Stock Unit +20,000 20,000
2023-02-15 Karrels James SVP, CFO and Secretary Grant or award · Employee stock option (right to buy) +180,000 180,000
2023-02-15 Karrels James SVP, CFO and Secretary Grant or award · Restricted Stock Unit +45,000 45,000
2023-02-15 Eck Stephen L. Chief Medical Officer Grant or award · Employee stock option (right to buy) +200,000 200,000
2023-02-15 Eck Stephen L. Chief Medical Officer Grant or award · Restricted Stock Unit +50,000 50,000
2023-02-14 BIOTECH TARGET N V 10% owner Purchase +500,000 $5.07 $2.5M 9,579,963
2023-01-19 BIOTECH TARGET N V 10% owner Purchase +150,000 $5.30 $795K 9,079,963
2023-01-03 Chhabra Meenu Director Grant or award · Stock Option (right to buy) +36,000 36,000
2023-01-03 Liu Margaret Director Grant or award · Stock Option (right to buy) +36,000 36,000
2022-12-27 BIOTECH TARGET N V 10% owner Purchase +200,000 $5.61 $1.1M 8,929,963
2022-12-23 BIOTECH TARGET N V 10% owner Purchase +200,000 $5.88 $1.2M 8,729,963
2022-11-22 BIOTECH TARGET N V 10% owner Purchase +300,000 $5.96 $1.8M 8,529,963
2022-10-28 Risser Eric Blasius Chief Operating Officer Exercise or conversion +8,500 $1.51 $13K 53,468
2022-10-28 Risser Eric Blasius Chief Operating Officer Exercise or conversion · Employee stock option (right to buy) −8,500 $1.51 $13K 0
2022-10-24 BIOTECH TARGET N V 10% owner Purchase +250,000 $4.36 $1.1M 8,229,963
2022-10-21 BIOTECH TARGET N V 10% owner Purchase +250,000 $4.63 $1.2M 7,979,963
2022-10-20 BIOTECH TARGET N V 10% owner Purchase +285,977 $4.00 $1.1M 7,729,963

Page 20 of 26 · 503 trades